Jefferson appoints Michael P. Harrington as the new chief financial officer.

Thomas Jefferson University, a prominent nonprofit institution based in Philadelphia, has appointed Michael P. Harrington as its new chief financial officer (CFO). Harrington, 56, is set to begin his role next month, following his tenure at the renowned Memorial Sloan Kettering Cancer Center in New York, where he served as CFO since 2019. He takes over from John Mordach, who unexpectedly left the organization earlier this year.

Jefferson’s president and CEO, Joseph G. Cacchione, expressed confidence in Harrington’s qualifications, highlighting his extensive financial expertise and history of spearheading transformative initiatives at esteemed healthcare institutions. Cacchione noted the importance of Harrington’s background as the university navigates an increasingly complex healthcare landscape.

Before his leadership role at Memorial Sloan Kettering, Harrington held the position of associate CFO at the Cleveland Clinic in Ohio for 12 years. During this time, he worked closely with Cacchione, establishing a foundation of collaboration and shared experience that is expected to benefit Jefferson moving forward.

In a statement regarding his new appointment, Harrington expressed enthusiasm about joining Jefferson at a crucial juncture in the healthcare sector. He emphasized his commitment to collaborating with the talented team at Jefferson to fulfill the institution’s mission of delivering exceptional patient care, advancing research, and enhancing the educational experience for students.

Harrington is set to assume his new role at Jefferson less than a year after the university completed its significant acquisition of Lehigh Valley Health Network. This merger has positioned Jefferson as a formidable entity in the healthcare industry, boasting approximately billion in annual revenue, a workforce of 65,000 employees, and an expansive portfolio of 32 hospitals, several of which are involved in joint ventures.

With an annual revenue of .5 billion and a staff of 22,000, Memorial Sloan Kettering has been a leader in cancer care and research, making Harrington’s experience particularly valuable to Jefferson as it aims to expand its service offerings and operational efficiency.

Following Mordach’s departure, Thomas Marchozzi, who served as the interim CFO, will transition to his permanent role as Jefferson’s chief integration officer. This change underscores Jefferson’s ongoing commitment to enhancing its operational structure while ensuring a smooth integration of its recent expansions. As the institution continues to evolve, the strategic leadership of Michael P. Harrington is anticipated to play a vital role in shaping the future of Thomas Jefferson University.